Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer

Frederiek F. van Doormaal*, Marcello Di Nisio, Hans-Martin Otten, Dick J. Richel, Martin Prins, Harry R. Buller

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2071-2076
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2011

Cite this